Lifecore Biomedical, Inc. LFCR
Set alert
6.42 USD +0.03 +0.47%
As of Nov 3, 10:02 AM ET
6.41 Day range 6.42
3.63 52-week range 8.98
- YTD
- -21.52%
- 1 year
- -9.70%
- Open
- 6.41
- Prev close
- 6.39
- Mkt cap
- 243.36M
- Vol
- 38.57K
- Avg vol
- 382.37K
- EPS
- -1.27
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.41
- High
- 6.42
- Forward P/E
- -9.90
- Beta
- 0.94
- Short ratio
- 11.20
- Inst. own
- 69.84%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 2, 2025
- 50-d avg
- 6.51
- 200-d avg
- 5.84
- 1y target
- 8.00
6M chart
Signals (24)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| RSI: Overbought | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 3, 2026 | 2 months ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 3 months ago |
| SMA: Bearish | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| SMA: Bearish | Jun 29, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
Newest 20 of 24.
Analyst view
Consensus: none
Price target (mean) 8.00 +24.6% upside
Now 6.42
- Target (low)
- 6.00
- Target (mean)
- 8.00
- Target (high)
- 10.00
Ratings (0m) 3 1 buy · 2 hold · 0 sell
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.305 | -0.34 – -0.27 | -0.0682 | -347.2% | 29.75M | -1.3% | 2 |
| Next quarter | -0.155 | -0.16 – -0.15 | 0.425 | -136.5% | 34.74M | -2.7% | 2 |
| Current year | -0.985 | -1.03 – -0.94 | -0.322 | -205.9% | 128.55M | +0.2% | 2 |
| Next year | -0.715 | -0.83 – -0.60 | -0.985 | +27.4% | 139.35M | +8.4% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 22, 2024 | Craig-Hallum | Maintained | Buy | Buy |
| Sep 5, 2024 | Craig-Hallum | Initiated | — | Buy |
| Aug 28, 2024 | Barrington Research | Downgrade | Outperform | Market Perform |
| Sep 1, 2023 | Barrington Research | Maintained | Outperform | Outperform |
| Sep 1, 2023 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Jun 2, 2023 | Barrington Research | Maintained | Outperform | Outperform |
| May 24, 2023 | Barrington Research | Maintained | Outperform | Outperform |
| Mar 21, 2023 | Barrington Research | Maintained | — | Outperform |
| Mar 20, 2023 | Barrington Research | Maintained | — | Outperform |
| Mar 20, 2023 | Stephens & Co. | Downgrade | Overweight | Equal-Weight |
| Mar 17, 2023 | Stephens & Co. | Reiterated | — | Overweight |